211 related articles for article (PubMed ID: 28922425)
1. Hypoxia-inducible factor-1 alpha as a therapeutic target for primary effusion lymphoma.
Shrestha P; Davis DA; Veeranna RP; Carey RF; Viollet C; Yarchoan R
PLoS Pathog; 2017 Sep; 13(9):e1006628. PubMed ID: 28922425
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of KAP1 enhances hypoxia-induced Kaposi's sarcoma-associated herpesvirus reactivation through RBP-Jκ.
Zhang L; Zhu C; Guo Y; Wei F; Lu J; Qin J; Banerjee S; Wang J; Shang H; Verma SC; Yuan Z; Robertson ES; Cai Q
J Virol; 2014 Jun; 88(12):6873-84. PubMed ID: 24696491
[TBL] [Abstract][Full Text] [Related]
3. A potential alpha-helix motif in the amino terminus of LANA encoded by Kaposi's sarcoma-associated herpesvirus is critical for nuclear accumulation of HIF-1alpha in normoxia.
Cai Q; Murakami M; Si H; Robertson ES
J Virol; 2007 Oct; 81(19):10413-23. PubMed ID: 17634230
[TBL] [Abstract][Full Text] [Related]
4. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen induction by hypoxia and hypoxia-inducible factors.
Veeranna RP; Haque M; Davis DA; Yang M; Yarchoan R
J Virol; 2012 Jan; 86(2):1097-108. PubMed ID: 22090111
[TBL] [Abstract][Full Text] [Related]
5. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ
mBio; 2018 May; 9(3):. PubMed ID: 29739902
[TBL] [Abstract][Full Text] [Related]
6. Kaposi's sarcoma-associated herpesvirus latent protein LANA interacts with HIF-1 alpha to upregulate RTA expression during hypoxia: Latency control under low oxygen conditions.
Cai Q; Lan K; Verma SC; Si H; Lin D; Robertson ES
J Virol; 2006 Aug; 80(16):7965-75. PubMed ID: 16873253
[TBL] [Abstract][Full Text] [Related]
7. The Kaposi's Sarcoma-Associated Herpesvirus ORF34 Protein Interacts and Stabilizes HIF-2α via Binding to the HIF-2α bHLH and PAS Domains.
Haque M; Kousoulas KG
J Virol; 2019 Sep; 93(17):. PubMed ID: 31189709
[TBL] [Abstract][Full Text] [Related]
8. Triptolide decreases expression of latency-associated nuclear antigen 1 and reduces viral titers in Kaposi's sarcoma-associated and herpesvirus-related primary effusion lymphoma cells.
Long C; Guo W; Zhou H; Wang J; Wang H; Sun X
Int J Oncol; 2016 Apr; 48(4):1519-30. PubMed ID: 26821279
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus enhances genome maintenance of Kaposi sarcoma-associated herpesvirus.
Bigi R; Landis JT; An H; Caro-Vegas C; Raab-Traub N; Dittmer DP
Proc Natl Acad Sci U S A; 2018 Nov; 115(48):E11379-E11387. PubMed ID: 30429324
[TBL] [Abstract][Full Text] [Related]
10. Latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells activates hypoxia-induced factors.
Carroll PA; Kenerson HL; Yeung RS; Lagunoff M
J Virol; 2006 Nov; 80(21):10802-12. PubMed ID: 16956952
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia and HIF-1α promote lytic
Lee S-C; Naik NG; Tombácz D; Gulyás G; Kakuk B; Boldogkői Z; Hall K; Papp B; Boulant S; Toth Z
J Virol; 2023 Nov; 97(11):e0097223. PubMed ID: 37909728
[TBL] [Abstract][Full Text] [Related]
12. HIF1α-Regulated Expression of the Fatty Acid Binding Protein Family Is Important for Hypoxic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus.
Singh RK; Bose D; Robertson ES
J Virol; 2021 May; 95(12):. PubMed ID: 33789996
[TBL] [Abstract][Full Text] [Related]
13. Genetic organization and hypoxic activation of the Kaposi's sarcoma-associated herpesvirus ORF34-37 gene cluster.
Haque M; Wang V; Davis DA; Zheng ZM; Yarchoan R
J Virol; 2006 Jul; 80(14):7037-51. PubMed ID: 16809309
[TBL] [Abstract][Full Text] [Related]
14. Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 3 stabilizes hypoxia-inducible factor-1 alpha to induce vascular endothelial growth factor expression.
Shin YC; Joo CH; Gack MU; Lee HR; Jung JU
Cancer Res; 2008 Mar; 68(6):1751-9. PubMed ID: 18339855
[TBL] [Abstract][Full Text] [Related]
15. Effects of ER stress on unfolded protein responses, cell survival, and viral replication in primary effusion lymphoma.
Shigemi Z; Baba Y; Hara N; Matsuhiro J; Kagawa H; Watanabe T; Fujimuro M
Biochem Biophys Res Commun; 2016 Jan; 469(3):565-72. PubMed ID: 26692493
[TBL] [Abstract][Full Text] [Related]
16. The Kaposi's sarcoma-associated herpesvirus ORF34 protein binds to HIF-1α and causes its degradation via the proteasome pathway.
Haque M; Kousoulas KG
J Virol; 2013 Feb; 87(4):2164-73. PubMed ID: 23221556
[TBL] [Abstract][Full Text] [Related]
17. Oncolytic Reactivation of KSHV as a Therapeutic Approach for Primary Effusion Lymphoma.
Zhou F; Shimoda M; Olney L; Lyu Y; Tran K; Jiang G; Nakano K; Davis RR; Tepper CG; Maverakis E; Campbell M; Li Y; Dandekar S; Izumiya Y
Mol Cancer Ther; 2017 Nov; 16(11):2627-2638. PubMed ID: 28847988
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1alpha.
Koh MY; Spivak-Kroizman T; Venturini S; Welsh S; Williams RR; Kirkpatrick DL; Powis G
Mol Cancer Ther; 2008 Jan; 7(1):90-100. PubMed ID: 18202012
[TBL] [Abstract][Full Text] [Related]
19. Altering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis.
Chandrasekharan JA; Huang XM; Hwang AC; Sharma-Walia N
J Virol; 2016 Dec; 90(24):11020-11031. PubMed ID: 27681120
[TBL] [Abstract][Full Text] [Related]
20. PX-478, an inhibitor of hypoxia-inducible factor-1alpha, enhances radiosensitivity of prostate carcinoma cells.
Palayoor ST; Mitchell JB; Cerna D; Degraff W; John-Aryankalayil M; Coleman CN
Int J Cancer; 2008 Nov; 123(10):2430-7. PubMed ID: 18729192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
